Amyl nitrite: Difference between revisions

(Created page with "==Administration== *Type: Antidote, anti-anginal agent *Dosage Forms: crushable ampules *Routes of Administration: inhalation *Common Trade Names: Component of Cyanide An...")
 
No edit summary
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
==Administration==
==Administration==
*Type: [[Antidote]], anti-anginal agent
*Type: [[Antidote]], anti-anginal agent
*Dosage Forms: crushable ampules  
*Dosage Forms: crushable ampules; liquid for inhalation
*Dosage Strengths: 0.3 mL
*Routes of Administration: inhalation
*Routes of Administration: inhalation
*Common Trade Names: Component of Cyanide Antidote Package (Lilly kit)
*Common Trade Names: Component of Cyanide Antidote Package (Lilly kit)
Line 9: Line 10:


==Pediatric Dosing==
==Pediatric Dosing==
 
*As above


==Special Populations==
==Special Populations==
Line 47: Line 48:
<references/>
<references/>


[[Category:Pharmacology]]
[[Category:Pharmacology]] [[Category:Toxicology]]

Latest revision as of 17:11, 19 September 2019

Administration

  • Type: Antidote, anti-anginal agent
  • Dosage Forms: crushable ampules; liquid for inhalation
  • Dosage Strengths: 0.3 mL
  • Routes of Administration: inhalation
  • Common Trade Names: Component of Cyanide Antidote Package (Lilly kit)

Adult Dosing

  • Cyanide toxicity: Crush one to two ampules in gauze, cloth, or a sponge and place under patient's nose, in O2 face mask, or port access of ETT. Patient should inhale deeply for 30s, rest for 30s, and repeat for 2-3 minutes

Pediatric Dosing

  • As above

Special Populations

Contraindications

  • Allergy to class/drug
  • Cerebral hemorrhage, recent severe head trauma

Adverse Reactions

Serious

  • Methemoglobinemia (this is the point when used for cyanide toxicity)
  • Raised ICP
  • Rased IOP
  • Syncope

Common

  • Orthostatic hypotension, dizziness
  • Headache
  • Flushing

Pharmacology

  • Half-life:
  • Metabolism:
  • Excretion:

Mechanism of Action

  • Convert the iron in hemoglobin from the ferrous to the ferric form, creating methemoglobinemia. Then, the thiosulfate can become sulfate donor, allowing conversion of cyanide to readily renally excretable form

Comments

See Also

References